{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T08:15:10Z","timestamp":1773735310524,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.healun.2006.04.005","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T02:57:51Z","timestamp":1153882671000},"page":"935-941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Similar Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS, Myfortic) Compared With Mycophenolate Mofetil (MMF) in De Novo Heart Transplant Recipients: Results of a 12-Month, Single-blind, Randomized, Parallel-group, Multicenter Study"],"prefix":"10.1016","volume":"25","author":[{"given":"Jon A.","family":"Kobashigawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale G.","family":"Renlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gino","family":"Gerosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Almenar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard J.","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Keogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans B.","family":"Lehmkuhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugolino","family":"Livi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nizar","family":"Yonan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2006.04.005_bib1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","article-title":"A mammalian protein targeted by G1-arresting rapamycin\u2013receptor complex","volume":"369","author":"Brown","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.healun.2006.04.005_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1993.tb00652.x","article-title":"Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil","volume":"136","author":"Allison","year":"1993","journal-title":"Immunol Rev"},{"key":"10.1016\/j.healun.2006.04.005_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2006.04.005_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate mofetil","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug Safety"},{"key":"10.1016\/j.healun.2006.04.005_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1034\/j.1399-0012.2003.00026.x","article-title":"The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation","volume":"17","author":"Pelletier","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2006.04.005_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1600-6143.2003.00321.x","article-title":"Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients","volume":"4","author":"Budde","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2006.04.005_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients","volume":"4","author":"Salvadori","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2006.04.005_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","article-title":"Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients","volume":"24","author":"Eisen","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.005_bib9","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/00007890-200111270-00015","article-title":"Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization","volume":"72","author":"Hosenpud","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2006.04.005_bib10","first-page":"444","article-title":"Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443)","volume":"13","author":"Kirklin","year":"1994","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.005_bib11","first-page":"571","article-title":"Mycophenolate mofetil (RS-61443)","volume":"113","author":"Taylor","year":"1994","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.005_bib12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00007890-199503150-00002","article-title":"Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement","volume":"59","author":"Gregory","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2006.04.005_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001573-199803000-00008","article-title":"Mycophenolate mofetil in cardiac transplantation","volume":"13","author":"Kobashigawa","year":"1998","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.healun.2006.04.005_bib14","first-page":"II-490","article-title":"Mycophenolate mofetil (MMF) depresses antibody production after cardiac transplantation","volume":"102","author":"Rose","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2006.04.005_bib15","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S1053-2498(02)00440-0","article-title":"Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients","volume":"21","author":"Weigel","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.005_bib16","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1053-2498(03)00100-1","article-title":"Mycophenolate mofetil significantly reduces leukocyte graft infiltration after heterotopic cardiac transplantation in a rat model","volume":"22","author":"Richter","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.005_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1053-2498(03)00097-4","article-title":"Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy","volume":"23","author":"Pethig","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.005_bib18","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1053-2498(02)00498-9","article-title":"The registry of the International Society for Heart and Lung Transplantation","volume":"21","author":"Hertz","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2006.04.005_bib19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1399-0012.1996.tb00661.x","article-title":"Mycophenolate mofetil (MMF) in heart transplantation","volume":"10","author":"Renlund","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2006.04.005_bib20","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.healun.2004.12.112","article-title":"Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus","volume":"24","author":"Mardigyan","year":"2005","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249806003287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249806003287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:12:55Z","timestamp":1760947975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249806003287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S1053249806003287"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2006.04.005","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Similar Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS, Myfortic) Compared With Mycophenolate Mofetil (MMF) in De Novo Heart Transplant Recipients: Results of a 12-Month, Single-blind, Randomized, Parallel-group, Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2006.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}